By Karen Braun HOFFMAN ESTATES, Illinois (Reuters) – U.S. gymnast Simone Biles will return to the competition floor in suburban Chicago on Saturday, two years after the “twisties” forced her to withdraw from team finals at the Tokyo Olympics. Biles, a seven-time Olympic and 25-time world medallist, showed off routines on all four apparatus in …
Biles to compete at U.S. Classic after two-year hiatus Read More »
By Kanishka Singh WASHINGTON (Reuters) – A Texas man who suggested a “mass shooting of poll workers” in 2022 elections and threatened two Maricopa County, Arizona, officials and their children was sentenced to 3-1/2 years in federal prison, the U.S. Justice Department said on Friday. Frederick Francis Goltz, 52, pleaded guilty in April to interstate …
Texas man who suggested ‘mass shooting of poll workers’ sentenced to 3-1/2 years Read More »
By Lucia Mutikani WASHINGTON (Reuters) – The U.S. economy added fewer jobs than expected in July, but solid wage gains and a decline in the unemployment rate back to 3.5% pointed to continued tightness in labor market conditions. The Labor Department’s employment report on Friday also showed job gains in May and June were revised …
US job growth slowing, but wage gains remain strong Read More »
By Nate Raymond (Reuters) -A divided federal appeals court on Friday ruled that Mississippi cannot strip the right to vote from thousands of convicts after they complete their sentences, calling that a “cruel and unusual punishment” that disproportionately affected Black people. A 2-1 panel of the New Orleans-based 5th U.S. Circuit Court of Appeals faulted …
Mississippi cannot strip convicts of right to vote, court rules Read More »
By Andrew Goudsward (Reuters) – Former U.S. President Donald Trump has assembled overlapping teams of lawyers as he balances mounting legal peril with his 2024 election campaign to return to the White House. Trump has pleaded not guilty to all charges in each of the three cases he has been indicted. Here are the main …
Factbox-Trump’s overlapping assortment of defense lawyers Read More »
By Sarah N. Lynch and Jacqueline Thomsen WASHINGTON (Reuters) – The judge in former U.S. President Donald Trump’s upcoming trial over his handling of classified documents made two errors in a June trial, including one that potentially violated the defendant’s constitutional rights and could have invalidated the proceedings, according to legal experts and a court …
Exclusive-Trump documents case judge made multiple errors in earlier unrelated trial Read More »
By Andrew Hay (Reuters) -“Rust” armorer Hannah Gutierrez on Friday waived her right to a preliminary hearing, allowing charges against her over the 2021 shooting death of the movie’s cinematographer, Halyna Hutchins, to move toward a possible trial. In a court filing, Gutierrez’s lawyer Jason Bowles waived the hearing set for Aug. 9-16 at which …
‘Rust’ film armorer waives hearing, shooting case may now go to trial Read More »
By Leah Douglas (Reuters) – The North Dakota Public Service Commission on Friday rejected a permit application from Iowa-based Summit Carbon Solutions to run 320 miles (514.99 km) of pipeline through the state to transport captured carbon dioxide from ethanol plants to an underground storage site. Summit is one of three companies, alongside Navigator CO2 …
North Dakota regulator rejects Summit Carbon Solutions carbon pipeline application Read More »
(This Aug. 3 story has been corrected to say ‘Justin Pearson’ instead of ‘Justin Nelson’ in paragraph 2) (Reuters) – Two Democratic lawmakers who were expelled from the Tennessee legislature earlier this year after angering the Republican majority with a protest against gun violence won a special election on Thursday to serve out the remainder …
Two expelled Democratic lawmakers reclaim seats in Tennessee special election Read More »
(Reuters) -The U.S. health regulator rejected Mesoblast’s cell therapy for children under 12 years of age for treating a type of complication that occurs after a stem cell or bone marrow transplant, sending its Australia-listed shares crashing about 58% on Friday. The U.S. Food and Drug Administration (FDA) required more data to support marketing approval …
Mesoblast shares tank after US FDA rejects cell therapy for children Read More »
